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Tobacco consumption contributes significantly to the global burden of disease. The preva-
lence of smoking is estimated to be increasing in many low-income countries, including Tan-
zania, especially among women and youth. Even so, the implementation of tobacco control
measures has been discouraging in the country. Efforts to foster investment in tobacco con-
trol are hindered by lack of evidence on what works and at what cost.
Aims
We aim to estimate the cost and cost-effectiveness of population-based tobacco control
strategies in the prevention of cardiovascular diseases (CVD) in Tanzania.
Materials and methods
A cost-effectiveness analysis was performed using an Excel-based Markov model, from a
governmental perspective. We employed an ingredient approach and step-down methodol-
ogies in the costing exercise following a government perspective. Epidemiological data
and efficacy inputs were derived from the literature. We used disability-adjusted life years
(DALYs) averted as the outcome measure. A probabilistic sensitivity analysis was carried
out with Ersatz to incorporate uncertainties in the model parameters.
Results
Our model results showed that all five tobacco control strategies were very cost-effective
since they fell below the ceiling ratio of one GDP per capita suggested by the WHO.
Increase in tobacco taxes was the most cost-effective strategy, while a workplace smoking
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ban was the least cost-effective option, with a cost-effectiveness ratio of US$5 and US$267,
respectively.
Conclusions
Even though all five interventions are deemed very cost-effective in the prevention of CVD
in Tanzania, more research on budget impact analysis is required to further assess the gov-
ernment’s ability to implement these interventions.
Introduction
Tobacco consumption contributes significantly to the global burden of disease. This risk factor
is attributable to seven out of ten leading causes of death globally, with cardiovascular diseases
(CVD), particularly ischemic heart disease (IHD), and stroke taking two of the top three posi-
tions [1]. Tobacco kills up to one in every two of its over 1.1 billion users; as such, there is no
other risk factor which represents such a high mortality rate [2]. The Global Burden of Disease
(GBD) study has estimated that 25% and 23% of the disability-adjusted life years (DALYs) due
to IHD and stroke respectively were attributable to tobacco use in 2013 [3]. Without compre-
hensive tobacco control policies, it is estimated that the annual death toll associated with
tobacco smoking will rise to over 8 million over the next 20 years, with more than 80% of these
deaths occurring in developing countries [4].
Even though many countries in sub-Saharan Africa (SSA) have no comprehensive data on
trends in tobacco use [5], it is estimated that the prevalence of smoking will increase in many
low-income countries (LICs), especially among women and youth, while in contrast it stabi-
lizes or declines in most higher-income countries [6]. Only as recently as the early 2000s did
some countries (including Tanzania) start collecting tobacco use data as part of the Demo-
graphic and Health Survey (DHS) [7]. Between 2005 and 2010, the prevalence of smoking has
remained stable at 21% for males but increased for females from 0.5% to 1.4% according to
Tanzania DHS (TDHS) reports [8, 9]. The World Health Organization’s (WHO) STEPwise
approach to non-communicable disease (NCD) risk factor surveillance for Tanzania showed
that smoking prevalence among males stands at 28% and among females it is 4.5% [10].
Globally, tobacco is associated with more than half a trillion dollars in economic damages
annually [2]. The consequences of tobacco on the economies of SSA countries are substantial
at both the individual and health-system levels. At the individual level, tobacco use can hinder
economic development both directly and indirectly. The direct effect occurs when expenditure
on tobacco takes priority over expenditure on food and education and indirectly when a high
proportion of the income is used on the treatment of tobacco-related diseases. This is even
more pronounced in LICs, where paying for health care mostly comes from out-of-pocket
expenditure [11]. Productive time is also lost when a person is sick and cannot participate in
production [12]. It follows, therefore, that CVD not only incurs lifelong disability but is also
expensive to treat. Such expenses will continue to put more pressure on already constrained
and weak health-care systems.
In recognition of the threat posed by tobacco use and exposure, the Framework Convention
on Tobacco Control (FCTC) was adopted by the World Health Assembly in 2003, and entered
into force in 2005. This international treaty prescribes evidence-based, cost-effective interven-
tions for reducing the supply and demand for tobacco [13]. Supply-side measures include
restrictions on sales to minors, while demand-side measures include, for instance, bans on
tobacco advertisements and protection from smoke exposure. Tanzania is one of the 168
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signatories that ratified the FCTC in 2004, meaning that the country is legally bound by the
treaty’s provisions [14].
In 2003, Tanzania approved a law relating to tobacco control: the Tobacco Product (Regula-
tion) Act (TPRA) [15]. This act regulates the manufacturing, labelling, distribution, sale and
promotion of tobacco products and smoking areas. Implementation of the act has been dis-
couraging, mainly due to the absence (until 2015) of accompanying regulations to guide its
implementation [16]. Furthermore, there is no national control program within the Ministry
of Health, Community Development, Gender, Elderly and Children (MoHCDGEC) to oversee
the implementation of these measures. Efforts by its proponents are thus fragmented between
non-governmental organizations like the Tanzania Tobacco Control Forum (TTCF) and the
Tanzania Public Health Association, the government through MoHCDGEC and international
organizations e.g. the WHO [17]. Conflicting messages from the Ministries of Agriculture and
Finance have also hindered the effective implementation of tobacco control measures. Their
motivation may have been influenced by the fact that tobacco producers are known to employ
significant numbers of rural Tanzanians and are among the largest taxpayers in the country
[17].
Regardless of these challenges to the employment and enforcement of the current act, the
effective implementation of tobacco control measures will require evidence of what works and
at what cost. While this has been extensively researched in many developed countries [18],
such information is scarce for Tanzania. Since context-specific evidence is important in in-
forming decision making [19], we aim to estimate the cost and cost-effectiveness of five popu-
lation-based tobacco control strategies: advertisement bans, package labelling of tobacco
products, smoke-free workplaces and public places, mass media campaigns and an increase in
tobacco product taxes in the prevention of CVD in Tanzania.
Methods
Two models were constructed in Microsoft Excel: prevalence and epidemiological models.
The former (prevalence model) was used to estimate smoking initiation and cessation rates,
and the latter (epidemiological model) combined these rates with other epidemiological
parameters, along with the cost and effectiveness of the analyzed tobacco interventions to
derive the cost-effectiveness ratios (CERs) among the base population.
Prevalence model
We adopted the prevalence model (see Fig 1) from original developers Mendez et al. [20] and
contextualized it with data from Tanzania to estimate smoking initiation and cessation rates.
The model has been used in similar studies in Australia, Italy and Vietnam [21–23].
Data. Observed smoking prevalence
The observed past prevalence among never smokers, current smokers (daily cigarette/
tobacco smokers) and former smokers for the age groups 25–34, . . . 65–74 and 75 were
based on survey data for 2002 and 2012 [10, 24]. For the age groups < 25 we used data from
the Global Youth Tobacco Survey (GYTS) carried out in 2003 and 2008 among adolescents
[25], which was assumed to reflect the smoking pattern of this age group. Data from the recent
Tanzania DHS, though nationally representative, was not chosen as one of the data sources for
past prevalence because data were aggregated in different age groupings (which did not match
the other two data sources), the definition of current smokers was not clear and the category of
former smokers was not reported. These smoking prevalence figures were then interpolated
and extrapolated linearly to obtain data for the missing years. Table 1 presents these values
from the data sources mentioned above.
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Calculated smoking prevalence
Probability of dying
The annual probabilities of dying in never, current and former smokers were estimated
from the age and sex-specific mortality rates for each smoking status. These mortality rates
were calculated from i) all-cause population mortality rates based on a Tanzanian life table for
2013 [26], ii) the observed smoking prevalence from the data sources explained above and iii)
the relative risk of mortality according to smoking status from the Cancer Prevention Study
(CPS) phase II (M Thun, personal communication). The use of a US-based study was moti-
vated by the lack within Tanzania of any such large-scale, context-specific prospective studies
which followed up millions of individuals with different smoking status over a long period.
The following formulas were applied to estimate the mortality rates and probabilities of dying
Fig 1. Overview of the smoking prevalence model for the base year population.
https://doi.org/10.1371/journal.pone.0182113.g001
Table 1. Observed smoking prevalence in Tanzania.
Current Former Never
Age Males Females Males Females Males Females Source
2002
<25 0.108 0.069 0.157 0.077 0.735 0.854
25–34 0.235 0.008 0.078 0.012 0.687 0.980
35–44 0.240 0.010 0.109 0.028 0.651 0.962
45–54 0.211 0.028 0.144 0.037 0.644 0.935 [24, 25]
55–64 0.197 0.053 0.186 0.081 0.616 0.866
65–74 0.174 0.042 0.229 0.089 0.597 0.869
>75 0.224 0.039 0.265 0.072 0.512 0.889
2012
<25 0.091 0.065 0.134 0.088 0.775 0.847
25–34 0.169 0.004 0.317 0.021 0.514 0.976
35–44 0.251 0.008 0.387 0.038 0.362 0.955
45–54 0.292 0.068 0.490 0.089 0.218 0.843 [10, 25]
55–64 0.236 0.041 0.476 0.131 0.288 0.828
65–74 0.263 0.039 0.457 0.091 0.280 0.870
>75 0.247 0.039 0.422 0.096 0.331 0.865
https://doi.org/10.1371/journal.pone.0182113.t001
Tobacco control in Tanzania




RRcx x Prevcx;t þ RR
f


















x;t = mortality rate for never, current and former smoking status respectively
in age group x and year t
Mpx;t = mortality rate of the total population in age group x and year t
Prevcx;t; Prev
f




x;t = relative risk of mortality in current and former smokers respectively com-
pared to never smokers in age group x and year t. The mortality rates (MR) for never, current
and former smokers for age group x and year t were then converted into the probability of
dying for age group x and year t using the formula: P = 1 − e−MR [27]
Number of smokers
We inferred the population size for the base year 2013 from the 2012 census by applying
age-specific fertility rates, sex ratio and mortality rates [28]. For the years analyzed, the popula-
tion was divided into never, current and former smokers based on: i) probability of dying
according to smoking status, ii) the proportional initiation and cessation among never and
current smokers respectively, and iii) fertility and sex ratio obtained and extrapolated from the
Tanzanian censuses of 2002 and 2012 and TDHS 2010 [9, 28, 29]. The formulas used to obtain
these numbers are presented in S1 Text. The estimated smoking prevalence was calculated as
the ratio of the number of individuals according to smoking status in a particular age group to
the total number of individuals in that age group.
Initiation and cessation rates
To estimate the unknown age-specific initiation and cessation rates in the model, a set of
values for these parameters that best fits the observed smoking prevalence was estimated by
means of an optimization routine. We used the generalized reduced gradient algorithm opti-
mization technique embedded in Solver, which is a Microsoft Excel add-in function. During
this process, we employed the weighted least squares method [20–23] using the inverse of the
variance of the observation as a set of weights for the observed prevalence to reflect the fact
that the different age groups in the four surveys have different sample sizes [30]. The estimated
initiation and cessation rates were assumed to be constant throughout the cohort’s lives unless
they were subjected to intervention effects (Table 2).
Representing uncertainty in initiation and cessation rates
Uncertainty intervals for these initiation and cessation rates were estimated by Monte Carlo
simulation with 10,000 iterations using Ersatz bootstrap software [31] by resampling the input
parameters from their assumed distributions. For relative risks of mortality according to
smoking status, lognormal distributions were fitted, while Dirichlet distributions were used
for the prevalence of never, current and former smokers. A beta distribution was used for
smoking cessation and initiation rates. These distributions were modified to have a lower
bound of -1 to allow for negative smoking initiation rates (i.e. cessation).
Tobacco control in Tanzania
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Epidemiological model
Decision model. A Markov model previously published in a similar work in Vietnam [22]
was used to bring together smoking initiation and cessation rates from the prevalence model,
epidemiological parameters, and the intervention cost and effect in order to estimate the costs,
health outcomes and cost-effectiveness ratios of five tobacco control strategies from a Tanza-
nian government perspective.
Four mutually exclusive health states were considered: “no history of CVD” (i.e. no previ-
ous IHD or stroke), “history of IHD”, and “history of stroke”. Finally, “death” was modelled as
an absorbing state (Fig 2). The Markov cohort consisted of 5-year age-groups of estimated Tan-
zanian population from 15–80+ years of age, i.e. 15–19, 20–24. . . 80+. The first cohort of 15–19
years was followed up until they were 80+. Since we assumed that smoking initiation does not
take place before 15 years of age, this cohort enters the model from the “no history of CVD”
health state and transits between the different health states according to age-specific risks for
each type of clinical event and depending on their risk profiles being influenced by their smok-
ing status (with and without adjustments from the intervention effects). The second to the
fourteenth cohort basically follow the same structure; however, depending on the estimated
incidence values of the two diseases modelled that mirror the other epidemiological parameters
for that age-group, some cohorts did not always start at the “no history of CVD” health state.
In the model, the risk of IHD and stroke were adjusted according to smoking status by cal-
culating the Potential Impact Factor, using the formula below [32]:
PIF ¼
P2






Prevx is the population smoking prevalence distribution for the cohort in base year 2013,
Prev^x is the future smoking prevalence before and after interventions, and RR is the relative
risk of contracting a disease depending on smoking status (Table 3), with 1 standing for non-
smokers and 2 for smokers.
At the end of each annual cycle, the health outcomes and costs associated with the different
health states were evaluated and accumulated.
Description of interventions. Five interventions namely advertisement, promotion and
sponsorship bans, package labelling of tobacco products, smoke-free public places, mass
media campaigns, and increasing the taxation on tobacco products were modelled. Table 4
provides further descriptions of the interventions, see S2 Text for a detailed decription). The
Table 2. Smoking initiation and cessation rates for the base year 2013.
Age Males Females
Mean Std. deviation Mean Std. deviation
<25 -0.0147 0.0076 -0.1801 0.0089
25–34 -0.0144 0.0024 0.5088 0.0441
35–44 0.0004 0.0079 0.0199 0.0242
45–54 -0.0177 0.0060 -0.0032 0.0010
55–64 -0.0039 0.0109 0.1200 0.0493
65–74 -0.0316 0.0108 0.0421 0.0441
>75 -0.0356 0.0110 0.0333 0.0474
Minus signs indicate smoking initiation otherwise the value indicates smoking cessation
https://doi.org/10.1371/journal.pone.0182113.t002
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scope of the measures included initial investment in revising the legislation, promotion and
advocacy in the first year, further sensitization and training in the third year and five years of
ongoing management and law-enforcement activities.
Input parameters. Transition probabilities
Data for the incidence of IHD and stroke and disease-specific mortality rates were obtained
from the GBD 2013 study [37, 38]. These were further modelled using DisMod II software
[39]. We assume that the incidence of each disease is independent of the other and indepen-
dent of all other causes of death except its own disease-specific mortality. We also assume that
Fig 2. Overview of the epidemiological Markov model. Health states: S1 = No history of CVD (i.e. IHD or
stroke), S2 = Histroy of IHD, S3 = History of stroke and S4 = Dead.
https://doi.org/10.1371/journal.pone.0182113.g002
Table 3. Annual risk of IHD and stroke among smokers compared to non-smokers.
Disease Age Male Female
RR 95% LCI 95% HCI RR 95% LCI 95% HCI
IHD 35–64 2.6 2.4 2.9 3.2 2.8 3.6
>65 1.5 1.3 1.6 1.7 1.6 1.9
Stroke 35–64 2.4 1.8 3.0 3.8 3.1 4.7
>65 1.5 1.2 1.8 1.6 1.4 1.9
IHD = Ischemic heart disease, RR = Relative risk, LCI = Low confidence interval, HCI = High confidence interval.
Source [33].
https://doi.org/10.1371/journal.pone.0182113.t003
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all causes of death are independent of each other. Age-specific background mortality rates
were based on a Tanzanian life table [26] and were adjusted for the mortality attributable to
IHD and stroke.
See Table 5 for a summary of parameters and sources.
Intervention costs
Tanzania does not have an established national tobacco control program and we therefore
conducted a costing study assuming an institutional setup adapted from the Tanzania Food
and Drug Authority (TFDA)–with some modifications (Fig 3). Most of the primary data were
collected from TFDA, which is a government organization under the MoHCDGEC responsi-
ble for regulating the quality and safety of food, drugs, cosmetics and medical devices. It
should be noted that TFDA has a somewhat different mandate, however. Being a governmen-
tal organization that has both headquarters and zonal offices and is primarily concerned with
regulation and law enforcement, it formed a suitable alternative for possible resource use for a
potential national tobacco control program. Three (out of five) of its directorates: the office of
the director general, the directorate of food safety and the directorate of business support,
related well to all the interventions considered in this work except tax increases. For instance,
activities under the inspection of banned/expired food products from stores and supermarkets
Table 4. Description of the tobacco control interventions analysed.
Intervention In country regulatory status WHO FCTC compliant/alignment
status




No comprehensive ban. Few forms of
tobacco advertisment and promotion
are prohibited specifically in radio and
television but it is unclear if the ban
applies to domestic print. There are
some restrictions on tobacco
sponsorship and the publicity of such
sponsorship.
To align with FCTC guidelines, the law
should prohibit all tobacco advertising
and promotion, including in domestic
newspapers and magazine. To clarify
the scope of the ban, the law should
provide a definition of “tobacco
advertising and promotion” in
accordance with the definition provided
in FCTC.
Comprehensive ban on
advertisement in all media outlets







TPRA indicates that “one of ten
authorized text messages” are to be
displayed. There is no guidance on
graphic display, size, format or
placement of the health warning.
To align to FCTC, TPRA and its
associated regulations should specify
size, placement, format and rotation of
the health messages. The message
should occupy 30% - 50% of the pack
and needs to be updated regularly.
Both graphic and text messages






Even though a public place is defined
in the TPRA, public transport is not.
Smoking is baned in public places,
however designated smoking areas
are still allowable in indoor public
places.
The TPRA and its associated
regulations needs to prohibit smoking
in all indoor public areas including hotel
rooms, prisons, public transport and
workplaces.
Different scenarios pertaining cost of





TPRA is silent. The law should stipulate the relevance
of information, education,
communication and other mass media
campaigns in the reduction of tobacco
consumption.
Implementation of a number of mass
media campaigns was considered.
Development and promotional of




The Tobacco (Imposition of Tax) Act
guides the imposition of tax on tobacco
sales. The total taxes on sold brand is
35% and excise taxes is less than
20%.
FTCT requires countries to adopt or
maintain measures which may include
implementing tax and price policies on
tobacco products so as to contribute to
the health objectives aimed at reducing
tobacco
Consumption.
Two scenario analyzed i) from
current rate to 50% and ii) from




WHO = World Health Organisation, FCTC = Framework Convention on Tobacco Control, TPRA = Tobacco Product (Regulation) Act
https://doi.org/10.1371/journal.pone.0182113.t004
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matches well with the inspection of smoke-free areas in workplaces and public spaces. Some of
the data for the human resource requirements of law enforcement were obtained from Ilala
municipality, Dar es Salaam, since TFDA has a mandate to use supplementary government
employees for law enforcement exercises. Cost data for the tobacco tax increase was obtained
from the Tanzania Revenue Authority (TRA), which assesses, collects and accounts for all cen-
tral government revenue. The departments costed included the office of the commissioner
general, the Large Taxpayers’ Department (LTD), where tobacco tax revenue is dealt with, and
five out of seven support departments (finance, human resource and development, informa-
tion and communication technology, research and policy departments).
We conducted detailed interviews with key personnel at both institutions to determine the
possible resource use for each of the interventions analyzed. We also inspected order books,
inventory records, issue vouchers and delivery notes so as to record all the equipment and sup-
plies consumed. Finance and procurement sections were consulted to determine the resources
used at the administrative level and overhead costs. Building costs were obtained by measuring
the area of the involved offices in square meters and, wherever necessary, physical counting of
equipment was performed.
The costing period was the fiscal year from July 2011 to June 2012. The costing exercise was
guided by the WHO’s tobacco costing tool, which is one of the modules in the overall non-com-
municable disease (NCD) costing tool [40–42]. Cost valuation followed an opportunity-cost
approach, whereby all resources are valued based on their best alternative use [43]. We used the
Tanzania Government Procurement Services Agency tender prices for equipment and supplies.
Rental charges for buildings were calculated according to National Housing Corporation (NHC)
rates. The prevailing market price was used as proxy for items whose prices were unavailable from
the data sources mentioned above. All costs were estimated in Tanzanian shillings (Tshs) and con-
verted to base year (2013) figures using a Tanzanian GDP deflator [44]. These were then con-
verted to US$ using the mean exchange rate for 2013 of Tshs1605/US$1 [45].
A cost analysis was performed within the epidemiological model described above. For all
the five interventions analyzed, we divided the resource use into six cost centers: a) strategy
Table 5. Model parameters and data sources.
Parameter Sources Reference
Prevalence Model
Population Census 2012 [28]
Age-specific fertility rate TDHS 2010 [9]
Sex ratio at birth TDHS 2010 [9]
Age and sex-specific overall mortality rates Tanzania life tables [26]
Mortality rates for never, current and former smokers CPSII M Thun, personal communication
Smoking prevalence rates Specific studies Table 1
Epidemiological model
Population Census 2012 [28]
Incidence and prevalence rates for IHD and stroke GBD 2013 and DisMod modelling [37]
Disease-specific mortality rates for IHD and stroke GBD 2013 and DisMod modelling [38]
Age and sex-specific background mortality rates Tanzania life tables [26]
Age-specific disability weights GBD 2013 [37]
RR of IHD and stroke among smokers compared to non-smokers Specific studies Table 3
Others
Intervention effects Specific studies Table 6
Intervention costs Primary data Table 7, S1 Table
https://doi.org/10.1371/journal.pone.0182113.t005
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development and evaluation, b) human resource requirements, c) promotion, media and
advocacy, d) program supplies, e) rent, equipment and office supplies and f) operations. Costs
were then identified as recurrent or capital costs. Capital costs were annuitized using a rate of
9.6%, which was the average interest rate for the year 2012/13 and their useful life years were
based on WHO assumptions [46, 47]. Capital items costing less than US$62 (TSh100 000)
were treated as recurrent costs. A step-down costing methodology was used to allocate shared
costs between the interventions using different allocation keys [48] (see S1 Table for more
details on cost breakdown and their associated cost-sharing assumptions).
Intervention effects
Intervention effects were based on data from published single studies. A recent systematic
review of tobacco control measures outlined the evidence for various effects estimates without
pooling due to the high heterogeneity in the characteristics of interventions, level of policy
enforcement and underlying tobacco control environment [49]. Most of the studies selected
reported effects sizes as odds ratios (OR), in which case a 2 by 2 table was constructed from the
Fig 3. The assumed tobacco control program organogram.
https://doi.org/10.1371/journal.pone.0182113.g003
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information given and relative risk (RR) was back-calculated. With the exception of price elas-
ticities, data was lacking from SSA or other developing countries. We therefore had to rely on
data from other regions. A 10-year time horizon was assumed for intervention effects (see
Table 6 for an overview of the studies considered), after which we assumed no further effects
(S3 Text provides further elaboration on the quantification of intervention effects on smoking
prevalence).
Health outcomes. Smoking influences the transition probabilities, and in the model
smoking interventions therefore translate into changes in CVD incidence and mortality which
are then converted into generic health outcomes measured in disability-adjusted life years
(DALYs) by using disability weights from GBD 2013. DALYs were then discounted at a rate of
3% [61]. For more details, refer to S4 Text.
Cost-effectiveness modelling. The expected costs and outcomes of the interventions
modelled were calculated independent of each other. Base-case results are presented as average
costs and effects and average cost effectiveness ratios (ICERs). Strategies having ACERs below
US$910, which was Tanzania’s 2013 GDP per capita [44], (the lowest willingness to pay
(WTP) value recommended by the WHO [62]) were considered “very cost-effective”.
Representing uncertainty. Probabilistic sensitivity analyses were performed to account
for the overall model uncertainty by running all the base-case parameters concurrently as dis-
tributions using Monte Carlo simulations. We performed 2000 iterations for each of the 14 age
groups modelled using Ersatz software [31]. We used PERT and a lognormal distribution for
intervention costs and effects, respectively [63].
Ethical statement
Ethical clearance was provided by the Ethical Review Committee of the Tanzania National
Institute of Medical Research with Ref. No. NIMR/HQ/R.8a/Vol. IX/136. Additionally, we
sought further permission to conduct the study from the Director General of Tanzania Food
and Drug Authority and Commissioner General of Tanzania Revenue Authority. We were
granted permission in writing and instructed to work with personnel in the relevant depart-
ments who further provided verbal informed consent to participate in the study.
Results
The annual cost and cost-effectiveness for the five interventions analyzed are provided in
Tables 7 and 8.
Costs
The total cost of the tobacco tax increase intervention was the lowest of the five interventions
modelled (US$1.7 million). Human resource requirements consumed the highest proportion
of total costs for all the interventions except mass media campaigns (Table 7).
Health effects
The health impact of the assessed interventions varied dramatically, ranging from close to
2,500 to about 250,000 DALYs averted. More DALYs are averted among males than females,
with the largest number of DALYs averted by tax increases (Table 8).
Cost-effectiveness
Cost-effectiveness ratios for all five interventions were compared against the status quo sce-
nario of no intervention for the base year. As shown in Table 8, average cost-effectiveness
Tobacco control in Tanzania
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Table 6. Effect size for tobacco control interventions on smoking initiation, cessation and prevalence.






Prevalence NA Review and
modelling
Various NA 4% +/- 20% Pert [50]









Initiation NR NR RR = 0.67
(0.49 to 0.87)
Lognormal [51]




labels; after introduction of
comprehensive warning










Initiation England Longitudinal (I) Complete ban in
restaurants and/or bars,
n = 632 (m) and 1,072 (f);
(B) No smoking bans,
n = 2,624 (m) and 4,158 (f).





Cessation UK Longitudinal (I) Complete ban in
restaurants and/or bars in
Scotland, n = 507; (B) other
















S: 1 –(I) Smoke-free
hospitals, n = 1033; (B)
Non-smoke-free
workplaces, n = 816. S:2 –
(I) Smoke-free work area;
(B) Non smoke-free work
area, n = 1844
Post-ban relapse
rate




n = 1033; (B) Non smoke-
free workplace, n = 816.














Cessation USA Longitudinal (I) TV campaign above
1218 GRPs between 1999–
2000; (B) TV campaign
below 1218 GRPs between
1999–2000











Initiation Vietnam Ela = -1.175
+/- 20%
Pert [59, 60]
Cessation Ela* = 0 NA
Note: Studies to be included in the modelling exercise were mostly chosen from the recent systematic review by Wilson LM et al. [49], evidence differed
considerably and no pooling of effects was undertaken, choice of individual studies depended on the quality reported in this review and, in a few cases,
authors’ choice. n–number; CI–confidence interval; NA–not applicable; RR–relative risk; NR–not reported; S1 –Study 1; S2 –Study 2; I–intervention; TO–
text only; G–graphic; B–baseline; m–males; f–females; GRPs–gross rating points
HR˚ –hazard ratio (effect size assumed to be the same as RR); Ela–elasticity
RR*/Ela*–assumed
RR^–reported from the primary study (all other RR estimates are calculated from OR).
https://doi.org/10.1371/journal.pone.0182113.t006
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ratios (ACER) were found to be below US$910–which is Tanzania’s GDP per capita for 2013–
per DALY averted. Interventions with a cost-effectiveness ratio below one and between one
and three times the GDP per capita per health effect have been recommended by the WHO to
be considered very cost-effective and cost-effective, respectively [62].
The most cost-effective strategy was a tax increase while the least cost-effective was a smok-
ing ban in workplaces, with ACER of US$5 and US$267 per DALY averted, respectively.
When incremental cost-effectiveness ratios were calculated, no intervention and increases in
tobacco tax dominated all of the four remaining interventions.
Representing uncertainty
Fig 4 presents a cost-effectiveness scatter plot to represent uncertainty around the model rec-
ommendations. All interventions are uncertain both in costs and effects, but the tax increase is
relatively more uncertain regarding effectiveness than costs.
Discussion
In this study we have quantified the health effects, costs, and cost-effectiveness of five demand-
side tobacco control preventive strategies for reducing the risk of CVD at the population level.
Our results suggest that the modelled interventions are all very cost-effective as they fall below
one times the GDP per capita for Tanzania for 2013, with a tobacco tax increase yielding the
most favorable cost-effectiveness ratio.
Table 7. Intervention cost of five demand-side tobacco control measures in US$.












52,710 52,710 52,710 - 145,535
Human resource
requirements
1,545,666 1,513,731 2,345,066 330,694 1,464,615
Promotion, media and
advocacy
107,267 107,267 107,267 739,172 7,765
Program supplies - - - 89,115 -
Rent, equipment and
office supplies
30,131 28,783 30,131 71,133 21,860
Operations 885,042 885,042 885,042 885,042 27,170
Total 2,620,816 2,587,533 3,420,216 2,115,156 1,666,945
https://doi.org/10.1371/journal.pone.0182113.t007
Table 8. Cost, effectiveness and cost-effectiveness for base-case tobacco control strategies in Tanzania.
Intervention Cost DALYs averted ACER ICER
Males Females Total
No intervention 0 0 0 0 0 _
Tobacco tax increase 1,547,355 249,126 38,706 287,832 5 5
Mass media campaigns 1,996,026 33,018 19,664 52,682 38 Dominated
Package labelling 2,248,370 44,903 11,269 56,174 40 Dominated
Advertisement ban 2,164,048 19,894 2,438 22,332 97 Dominated
Smoke-free public places 3,646,117 31,021 4,294 35,315 103 Dominated
Smoke-free workplaces 3,381,652 5,681 6,985 12,666 267 Dominated
DALYs = Disability-adjusted life years, ACER = Avergae cost-effectiveness ratio, ICER = Incremental cost-effectiveness ratio
https://doi.org/10.1371/journal.pone.0182113.t008
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While historically much of the cost-effectiveness evidence for tobacco control interventions
has come from high-income countries, data gathered and analyzed from low- and middle-
income countries show similar success. Results from many studies in South Africa have consis-
tently shown that an increase in tobacco tax is the single most cost-effective tobacco control
measure [64]. Taxation has been shown to have a three-fold effect on consumption: taxes pro-
vide a barrier to initiation, reduce consumption among current smokers, and prevent former
smokers from relapsing [65]. Since we did not find any studies from other context-specific set-
tings, we also compared our model conclusions with other studies conducted in WHO and
World Bank regions, and these also conform to our results [2, 5, 42, 66, 67]. A study from the
Republic of Moldova reveals that tobacco taxation dominates all other demand-side individual
and population-based interventions, except when all of the interventions were combined [68].
Although we did not explicitly model changes in tobacco revenue with increase in tobacco
taxes our intuition point towards a “win-win” situation of increase in revenue and decrease in
smoking prevalence. This is due to the opposite effect of price elasticity on prevalence and
smoking initiation which when coupled with rapid Tanzanian population growth would likely
lead to revenue increase [69]. Revenues generated from tobacco taxes can be substantial as
shown by Goodchild et al. who estimated an increase of 85% in the tax revenue base for Africa
[70]. Therefore, apart from the benefits of reducing tobacco consumption, utilizing a portion
of the tobacco tax revenues to fund, for instance, mass media public awareness campaigns and
cessation programs can further reduce tobacco consumption [17]. This has been achieved in
many countries globally, with a notable success story reported in Thailand [71].
Health care costs associated with tobacco and tobacco-related disease expenditure have
been shown to be significant [72]. Consequently, reduction in tobacco use would be expected
to lower these costs. However, a few studies that have estimated the economic impact of
Fig 4. Cost effectiveness scatter plot for the tobacco control strategies. Wplaces = work places,
Pplaces = public places.
https://doi.org/10.1371/journal.pone.0182113.g004
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smoking cessation in a lifetime perspective found other results [73]. Barendregt et al for
instance showed that nonsmokers (never smokers and ex-smokers) have 15% higher direct
lifetime health care costs due to longer life expetancies than smokers [74]. Tobacco-related ill-
nesses and premature mortality also impose high productivity costs to the economy because of
sick workers and those who die prematurely during their working years [75]. Consideration of
productivity losses into economic analyses still attracts a lot of debate and inclusion or exclu-
sion of these costs can influence results [76].
The health benefits and economic impact of tobacco control are broad and may extend far
beyond the health sector. The assessment of costs and outcomes in this analysis has been lim-
ited to benefits within the health sector, following the perspective and methodology of the
cost-effectiveness analysis employed. Other non-health benefits that might be important, such
as productivity gains, could be explored from a broader societal perspective [77].
our modelled interventions are estimated to be very cost-effective, however, it is worth
mentioning that these results should serve as inputs to the decision-making process regarding
population health improvement. In LICs like Tanzania, there may still be highly cost-effective
programs yet to be implemented both within and outside the health sector that compete for
the same resource base.
Strengths and limitations
Our use of initiation and cessation instead of prevalence rates alone has several advantages.
Firstly, it distinguishes between never and former smokers, who have different mortality rates
compared to current smokers, which cannot be captured using only prevalence rates. Sec-
ondly, modelling it this way also enabled us to capture different smoking behaviors between
age groups, since the young probably demonstrate high initiation while the older have high
cessation rates. Thirdly, different interventions for tobacco control act differently upon initia-
tion and cessation rates. Lastly, our projected base-case smoking prevalence compares favour-
ably with that estimated for Tanzania in the Global trends and projections for tobacco use (e.g.
0.198 versus 0.222 for males aged 25–64 in the year 2025) [78]. This comparison, however,
should be interpreted with caution due to the different modelling approaches employed.
These results should also be considered in light of model limitations. Firstly, our adaption of
this previously published model to Tanzania was not without data availability challenges. We
made use of much local data on costs and some epidemiological data, but no national data were
available on other epidemiological parameters; for instance: incidence, risk of death from smoking,
excess mortality from tobacco-related diseases and the effectiveness of tobacco control interven-
tions. In the absence of such information, we therefore derived epidemiological and effect esti-
mates from other international studies and the recent GBD study. Secondly, the absence of a body
that oversees tobacco control in Tanzania required us to make the conservative assumption that
tobacco control can be achieved using a similar government organization, which we then used as a
model for the costing exercise. Such an attempt could likely over- or under-estimate our cost esti-
mates. We made efforts to cost only the relevant departments according to our consultations with
experts in order to minimize this limitation. Thirdly, we did not take into consideration people
who repeatedly quit and relapse into smoking. Such an endeavor would require even more data
(which is unavailable) and complex models; however, their exclusion may not significantly affect
our results since this group is probably captured either in the former or current smoker group.
Fourthly, even though one may anticipate an increase in government revenue with an
increase in tobacco taxes, this is not the case when the effect of reduced consumption (fewer
units) outcrowds the effect of increased unit taxes. In this work, we did not undertake supple-
mentary analyses to explore the net impact on government revenue. Fifth, given our choice of
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a governmental perspective, including changes in tax revenue in the estimation of the cost-
effectiveness ratio could have been appropriate. Such an analysis might have impacted the
ACER results either negatively or positively. The overall effect of the changes in tobacco reve-
nue to the estimates of ACER remains an empirical question that depend on the price elasticity
of tobacco consumption. Sixth, the inclusion of only two smoking-related diseases (IHD and
stroke), even though they cover about 30% of the disease burden attributable to tobacco smok-
ing, likely underestimates the health gains related to tobacco control, pulling in our results in
the conservative direction. Lastly, we modelled our interventions as being independent of each
other, i.e. one by one in the absence of other interventions. This implies that the selection of
one intervention will not influence the costs or effectiveness of other, independent interven-
tions. However, this assumption is questionable in this case due to competing risk reductions.
If, for instance, tax reform is effectively introduced, the effect of the other interventions would
be lower because the baseline risk is changed. Consequently the resulting individual cost-effec-
tiveness ratios might therefore be optimistic when several are implemented simulateneously,
although this might be countered by economies of scale if several inititatives were coordinated
and introduced as bundles of interventions.
Conclusions
This study provides evidence on the cost and cost-effectiveness of tobacco control interven-
tions in Tanzania. The model results showed that five population-based tobacco control strate-
gies, namely: a ban on tobacco advertisements, package labelling of tobacco products, smoke-
free environments, mass media campaigns and tobacco taxation, offer good value for money
in the primary prevention of CVD in Tanzania. Despite these interventions being very cost-
effective, they should not automatically be recommended for implementation, but the evi-
dence should form a basis for discussion in the policy agenda to promote population health in
Tanzania. Additionally, a budget impact analysis should be conducted to assess the govern-
ment’s ability to implement these interventions.
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